Title : Considerations on the identification and management of metastatic prostate cancer patients with DNA repair gene alterations in the Canadian context.

Pub. Date : 2022 Apr

PMID : 34812730






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Olaparib is the first Health Canadaapproved agent in metastatic prostate cancer to use a companion diagnostic to identify alterations in BRCA1, BRCA2, or ATM. olaparib BRCA1 DNA repair associated Homo sapiens